Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a painful, dose-limiting adverse effect of commonly used chemotherapeutic agents. The purpose of this exploratory study was to evaluate the efficacy and safety of mirogabalin in patients with moderate to severe CIPN during chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Misawa, Sonoko, Denda, Tadamichi, Kodama, Sho, Suzuki, Takuji, Naito, Yoichi, Kogawa, Takahiro, Takada, Mamoru, Suichi, Tomoki, Shiosakai, Kazuhito, Kuwabara, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640752/
https://www.ncbi.nlm.nih.gov/pubmed/37951905
http://dx.doi.org/10.1186/s12885-023-11560-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640752/
https://www.ncbi.nlm.nih.gov/pubmed/37951905
http://dx.doi.org/10.1186/s12885-023-11560-4

Ejemplares similares